Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.13.23 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Jimin Han and 10 co-authors. Institution: Department of Ophthalmology, University of Rochester, Rochester, New York, United States. Major MEDLINE topics: Phagocytosis, Neuronal Ceroid-Lipofuscinoses, Electroretinography, Membrane Glycoproteins. Cited 7 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS.
Abstract (original language)
Purpose
CLN3 Batten disease (also known as juvenile neuronal ceroid lipofuscinosis) is a lysosomal storage disorder that typically initiates with retinal degeneration but is followed by seizure onset, motor decline and premature death. Patient-derived CLN3 disease induced pluripotent stem cell-RPE cells show defective phagocytosis of photoreceptor outer segment (POS). Because modifier genes are implicated in CLN3 disease, our goal here was to investigate a direct link between CLN3 mutation and POS phagocytosis defect.
Methods
Isogenic control and CLN3 mutant stem cell lines were generated by CRISPR-Cas9-mediated biallelic deletion of exons 7 and 8. A transgenic CLN3Δ7-8/Δ7-8 (CLN3) Yucatan miniswine was also used to study the impact of CLN3Δ7-8/Δ7-8 mutation on POS phagocytosis. POS phagocytosis by cultured RPE cells was analyzed by Western blotting and immunohistochemistry. Electroretinogram, optical coherence tomography and histological analysis of CLN3Δ7-8/Δ7-8 and wild-type miniswine eyes were carried out at 6, 36, or 48 months of age.
Results
CLN3Δ7-8/Δ7-8 RPE (CLN3 RPE) displayed decreased POS binding and consequently decreased uptake of POS compared with isogenic control RPE cells. Furthermore, wild-type miniswine RPE cells phagocytosed CLN3Δ7-8/Δ7-8 POS less efficiently than wild-type POS. Consistent with decreased POS phagocytosis, lipofuscin/autofluorescence was decreased in CLN3 miniswine RPE at 36 months of age and was followed by almost complete loss of photoreceptors at 48 months of age.
Conclusions
CLN3Δ7-8/Δ7-8 mutation (which affects ≤85% of patients) affects both RPE and POS and leads to photoreceptor cell loss in CLN3 disease. Furthermore, both primary RPE dysfunction and mutant POS independently contribute to impaired POS phagocytosis in CLN3 disease.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, University of Rochester, Rochester, New York, United States.
- Department of Biomedical Genetics, University of Rochester, Rochester, New York, United States.
- Center for Visual Science, University of Rochester, Rochester, New York, United States.
- Wicking Dementia Research and Education Centre, University of Tasmania, Tasmania, Australia.
- Pediatrics & Rare Diseases Group; Sanford Research, Sioux Falls, South Dakota, United States.
- Department of Pediatrics; Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota, United States.
Funding
- NEI NIH HHS
Cite
APA
Han, J., Chear, S., Talbot, J., Swier, V., Booth, C., Reuben-Thomas, C., Dalvi, S., Weimer, J. M., Hewitt, A. W., Cook, A. L., & Singh, R. (2024). Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.13.23
Vancouver
Han J, Chear S, Talbot J, Swier V, Booth C, Reuben-Thomas C, et al. Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.13.23
BibTeX
@article{Han2024,
author = {Han, Jimin and Chear, Sueanne and Talbot, Jana and Swier, Vicki and Booth, Clarissa and Reuben-Thomas, Cheyenne and Dalvi, Sonal and Weimer, Jill M and Hewitt, Alex W and Cook, Anthony L and Singh, Ruchira},
title = {Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.13.23}
}
EUVIMED